Single Source for the Continuation of the Data Management and Coordinating Center (DMCC) for Rare Diseases Clinical Research Network (RDCRN) (U2C Clinical Trial Not Allowed)
ID: 353422Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Public and State Controlled Institutions of Higher Education

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353422

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-TR-24-021.html
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Apr 5, 2024 12:00 AM
  4. 4
    Due Jul 22, 2024 12:00 AM
Description

The National Institutes of Health (NIH) is seeking a single source for the continuation of the Data Management and Coordinating Center (DMCC) for the Rare Diseases Clinical Research Network (RDCRN). This funding opportunity aims to support the DMCC at Cincinnati Children's Hospital Medical Center (CCHMC). The RDCRN is focused on advancing and improving the diagnosis, management, and treatment of various rare diseases through collaborative, multi-site, patient-centric research.

The DMCC plays a crucial role in facilitating and supporting the activities of individual Rare Diseases Clinical Research Consortia (RDCRCs) as well as trans-network activities. It provides administrative support, data management support, clinical research support, patient engagement, and broad dissemination of information. The ultimate goal is to enhance rare disease research by identifying individuals with rare diseases early on and ensuring clinical trial readiness.

This funding opportunity is non-competitive and intends to fund a single award. The grant does not require cost sharing or matching. Public and State Controlled Institutions of Higher Education are eligible to apply. Non-domestic entities and components of U.S. organizations are not eligible to apply. The deadline for application submission is July 22, 2024.

For more information and to apply, please visit the following link: Additional Information. If you have any inquiries, please contact NIH Grants Information at grantsinfo@nih.gov.

Point(s) of Contact
grantsinfo@nih.gov
Files
Title
Posted
RFA-TR-24-021.html
4/20/2024
Similar Opportunities
Notice of Intent to Publish a Funding Opportunity Announcement for Data Management and Coordinating Center (DMCC) for Rare Diseases Clinical Research Network (RDCRN) (U2C Clinical Trial Not Allowed)
Active
National Institutes of Health
The National Institutes of Health (NIH) plans to publish a Funding Opportunity Announcement (FOA) for the Data Management and Coordinating Center (DMCC) for the Rare Diseases Clinical Research Network (RDCRN). The DMCC will support the activities of the Rare Diseases Clinical Research Consortia (RDCRC) and facilitate the advancement of rare disease research. This FOA is expected to be published in 2024, with an estimated award date in 2025. The DMCC will play a crucial role in advancing the diagnosis, management, and treatment of rare diseases through collaborative, translational, and clinical research. The FOA will utilize the U2C activity code and will provide funding of approximately $1,000,000. Potential applicants are encouraged to develop meaningful collaborations and responsive projects. For more information, please contact Tiina K. Urv, Ph.D. at urvtiin@mail.nih.gov or 301-827-2746.
Notice of Intent to Publish a Notice of Funding Opportunity (NOFO) for the Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN)
Active
National Institutes of Health
The National Institutes of Health (NIH) plans to publish a Notice of Funding Opportunity (NOFO) for the Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN). This NOFO aims to solicit applications for research that will advance the diagnosis, management, and treatment of rare diseases. The RDCRC will facilitate collaborative, multi-site, patient-centric, translational, and clinical research. It is encouraged that the RDCRC study outcome measures address unmet clinical trial readiness needs to propel the field of research forward. Potential applicants are provided with sufficient time to develop collaborations and projects. The NOFO is expected to be published in winter 2024, with an application due date in summer 2024. The funding will be in the form of a Cooperative Agreement, and there is no cost sharing or matching requirement. The estimated total program funding is $1,000,000. The NOFO will utilize the U54 activity code, which supports specialized centers through multi-project cooperative agreement awards with substantial involvement from NIH program staff. The estimated synopsis post date is January 24, 2024, and the estimated synopsis close date is June 14, 2024. The estimated award date and project start date are both July 1, 2025.
Notice of Intent to Publish a Funding Opportunity Announcement for the Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN)
Active
National Institutes of Health
The National Institutes of Health (NIH) plans to publish a Funding Opportunity Announcement (FOA) for the Rare Diseases Clinical Research Consortia (RDCRC) in the Rare Diseases Clinical Research Network (RDCRN). This funding opportunity aims to advance the diagnosis, management, and treatment of rare diseases. The RDCRC will support highly collaborative, multi-site, patient-centric, translational, and clinical research. It is encouraged that the RDCRC study outcome measures address unmet clinical trial readiness needs to advance the field of research. Potential applicants are provided with sufficient time to develop collaborations and projects. The FOA is expected to be published in 2024, with an application due date in 2024. The funding will be provided through cooperative agreement awards utilizing the U54 activity code. For more information, contact Tiina K. Urv, Ph.D. at urvtiin@mail.nih.gov or 301-827-2746.
Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
Active
National Institutes of Health
The National Institutes of Health is seeking a Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials through a Cooperative Agreement. This opportunity falls under the category of Health and is open to eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions, and more. The purpose of this funding is to support applications for a collaborating Data Coordinating Center (DCC) for investigator-initiated multi-site clinical trials. The DCC will provide overall project coordination, administration, data management, and biostatistical support for the clinical trial proposed in the collaborating Clinical Coordinating Center (CCC) application. The deadline for submission is September 11, 2025. For more information and to apply, visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAR-22-193.html](http://grants.nih.gov/grants/guide/pa-files/PAR-22-193.html).
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
Active
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)". This grant aims to support clinical projects that address critical needs for clinical trial readiness in rare diseases. The funding will enable the efficient and effective movement of candidate therapeutics or diagnostics towards clinical trials, increase the likelihood of success through the development and testing of rigorous biomarkers and clinical outcome assessment measures, and enable the design of upcoming clinical trials by defining the presentation and course of a rare disease. The grant does not require cost sharing or matching. The maximum award ceiling is $275,000. Other eligible applicants include Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions, Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities, Indian/Native American Tribal Governments, Non-domestic Entities, Regional Organizations, Tribally Controlled Colleges and Universities, U.S. Territories or Possessions. Non-domestic entities and components of U.S. organizations are not eligible to apply. The deadline for application submission is October 17, 2024. For more information and to apply, visit the following link: [Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes Grant](http://grants.nih.gov/grants/guide/pa-files/PAR-23-159.html). For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.